Trials / Completed
CompletedNCT02280590
Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 223 (actual)
- Sponsor
- Dong-A ST Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Comparison of the efficacy and safety of Cresnon® and Crestor® in patients with hyperlipidemia \- 8-week, active-controlled, open-label, randomized, parallelgroup, fixed-dose, noninferiority, multicenter, phase 4 design
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rosuvastatin(Cresnon®) | 10mg |
| DRUG | Rosuvastatin(Crestor®) | 10mg |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2015-06-01
- First posted
- 2014-10-31
- Last updated
- 2015-07-07
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02280590. Inclusion in this directory is not an endorsement.